Glenmark Pharmaceuticals has posted a consolidated net profit of Rs 457.83 crore for the year ended March 31, 2011.

The consolidated net profit during the previous fiscal stood at Rs 331.03 crore, the company said in a filing to the Bombay Stock Exchange.

As the company has adopted a new accounting system, the consolidated figures are not comparable with those of the previous fiscal.

Total income of the company for the year ended March 31, 2011 stood at Rs 3,089.58 crore against Rs 2,533.80 crore in the previous fiscal.

The board has recommended a dividend of Re 0.40 per share (40 per cent) of face value Re 1 on the equity share capital of the company for the financial year 2010-2011.

comment COMMENT NOW